APA (7th ed.) Citation

F, V., M, C., M, B., M, D., B, S., C, S., . . . WC, B. (2025). Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor. Journal of medicinal chemistry, 68(11), 10631. https://doi.org/10.1021/acs.jmedchem.5c00529

Chicago Style (17th ed.) Citation

F, Vallée, et al. "Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor." Journal of Medicinal Chemistry 68, no. 11 (2025): 10631. https://doi.org/10.1021/acs.jmedchem.5c00529.

MLA (9th ed.) Citation

F, Vallée, et al. "Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor." Journal of Medicinal Chemistry, vol. 68, no. 11, 2025, p. 10631, https://doi.org/10.1021/acs.jmedchem.5c00529.